Anticholinesterasic drugs: tacrine but not physostigmine, accumulates in acidic compartments of the cells.
Tacrine (THA) and physostigmine (PHS) have been used in Alzheimer's disease therapy for their anticholinesterasic activity. Here we show that THA is taken up in rat lysosomes in an energy-dependent manner, and that it is also accumulated in acidic compartments of rat thymocytes and neuroblastoma cells. A concentration of THA less than 1 mM dissipated the pH gradient (delta pH) in all the above mentioned in vitro systems. On the contrary higher concentrations of PHS (1-2 mM) were ineffective. The accumulation of THA in acidic organelles of the cell may be relevant for the pharmacological action of THA in Alzheimer's treatment.
Dell'Antone
P
P
Dipartimento di Scienze Biomediche Sperimentali, Università and di Padova, Italy.
Bragadin
M
M
Zatta
P
P
D000165:Acridine Orange / Q000493:pharmacokinetics; D000544:Alzheimer Disease / Q000188:drug therapy / Q000378:metabolism; D000818:Animals; D001693:Biological Transport, Active; D002460:Cell Line; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism; D008247:Lysosomes / Q000378:metabolism; D008297:Male; D051379:Mice; D015388:Organelles / Q000378:metabolism; D010830:Physostigmine / Q000493:pharmacokinetics*; D051381:Rats; D017208:Rats, Wistar; D013601:T-Lymphocytes / Q000378:metabolism; D013619:Tacrine / Q000493:pharmacokinetics* / Q000494:pharmacology
D013619:Tacrine; D010830:Physostigmine; D000165:Acridine Orange